X

Our vision is to transform protein production by harnessing the power of insects to provide universal access to protein-based biologics in animal and human health.

Improved baculovirus vectors

Proprietary Baculovirus expression cassette that allows significant yield increases, long-lasting expression and reduces protein proteolysis.

Learn more
+

Disruptive manufacturing process

Harnessing the power of insects to act as natural single-use bioreactors with chrysalises from the Trichoplusia ni Lepidopter as production tool.

Learn more
=

CrisBio® is a patent protected technology that enables productivity of gram/liter levels

  • Simple manufacturing
  • Almost unlimited linear scalability
  • High versatility
  • High efficiency: Incorporates TopBac as productivity booster
  • Significant savings in production costs
Insect rearing in disposable boxes

Insect rearing in disposable boxes

Pupae desilking (automated)

Pupae desilking (automated)

Clean pupae

Clean pupae

Pupae pick & place (automated)

Pupae pick & place (automated)

Automated pupae inoculation
Baculovirus generation Baculovirus generation

Automated pupae inoculation

Frozen pupae biomass

Frozen pupae biomass

Downstream

Downstream

Purified protein

Purified protein

GMP

RFID-tagged disposable trays

RFID-tagged disposable trays

1 of 3

Insect rearing in disposable boxes

Insect rearing in disposable boxes

Pupae desilking (automated)

Pupae desilking (automated)

Clean pupae

Clean pupae

Pupae pick & place (automated)

Pupae pick & place (automated)

RFID-tagged disposable trays

RFID-tagged disposable trays

Automated pupae inoculation

Automated pupae inoculation

Baculovirus generation Baculovirus generation

GMP

Frozen pupae biomass

Frozen pupae biomass

GMP

Downstream

Downstream

GMP

Purified protein

Purified protein

GMP

AREAS OF FOCUS

Animal Health

20 years’ experience in the development and production of animal vaccines.
> 200 molecules successfully produced in collaboration with public and private partners, including multiple international pharmaceutical companies.
First dossier for a veterinary vaccine produced using CrisBio® under review by EMA.

Learn more

Human Health

Building on experience in animal health, Algenex is expanding the production of proteins into human health to fully exploit the potential of its technology platforms

Learn more

EVENTS & NEWS

News

24/09
Company CrisBio Technology

Algenex inaugura su nueva planta de fabricación de vacunas e...

Inauguración de la nueva planta de Algenex en Tres Cantos (Madrid)
Learn more

News

13/09
CrisBio Company

Algenex raises €7.4 million in financing round

Algenex R&D Laboratory at Tres Cantos (Madrid)
Learn more

News

08/09
CrisBio Company

Algenex cierra nueva ronda de financiación por 7,4 millones ...

Laboratorio I+D Algenex en Tres Cantos (Madrid)
Learn more